Prescription of Letrozole for Uterine Myoma
Letrozole for Treatment of Uterine Fibroids: A Randomized, Placebo-Controlled Trial
University of California, San Francisco
140 participants
Jul 24, 2024
INTERVENTIONAL
Conditions
Summary
The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Oral letrozole 2.5mg/day
Placebo capsule
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06143631